<a href=" http://www.ccfgb.co.uk/accutane-20mg-journal-articles.pdf ">accutane 20mg journal uqam</a> The researchers noted that the compound had been patented in 1988 by Knoll Pharmaceuticals with claims of psychoactive effects such as enhancing mental activities and pain tolerance. While it was never developed into a medicine the patent described tests on animals and suggested an intended oral dose of 10 mg to 150 mg with a target of 30 mg. さんの一首